Know Your Dressings: Collagen Dressings For Wound Healing

Wound healing occurs as the body naturally restores damaged tissue. Wound healing is a complex series of events and interactions that result in an orderly process with 3 overlapping, yet distinct stages.
Collagen Dressings

What interferes with wound healing?
Unfortunately, there are times when the wound fails to progress through the orderly wound healing process. This is commonly the result of an extended inflammatory phase, often caused by increased matrix metalloproteases (MMP’s) in the wound. 2 MMP’s are necessary to break down damaged tissue, however too many can destroy the healthy extracellular matrix and impede wound healing. Bioburden, or the presence of biofilm in the wound, can also delay the wound healing process. 5 When delayed wound healing occurs, collagen dressings can restart the wound healing cascade. Read more ›

Posted in Clinical Insights Newsletter

Know Your Dressings: Calcium Alginates, CMC, and Gelling Fibers

Successful wound care involves selecting the appropriate dressing to optimize the wound healing environment. Dressing selection plays an important role in supporting autolytic debridement and promoting wound healing. 1 Wounds with heavy drainage require dressings that are absorptive, yet still maintain a moist wound environment to promote healing, such as calcium alginate or carboxymethylcellulose (CMC) gelling fiber dressings.

What is a calcium alginate dressing?
Calcium alginate dressings are made from sodium alginate extracted from brown seaweed and processed with calcium salts into nonwoven biodegradable dressings. 2 Alginate dressings can be found in sheet or rope form. The dressings uniquely gel as they come in contact with wound exudate to provide a moist wound environment that facilitates autolytic debridement. The dressings can fill wound dead space and absorb up to 20 times their weight in exudate depending on the manufacturer’s process. 3
What is a CMC gelling fiber dressing?
Carboxymethylcellulose (CMC) dressings are highly absorptive textile fiber dressings derived from natural cellulose sources and are commonly known as CMC gelling fiber dressings. 9 CMC dressings form a transparent moist gel as they bind wound exudate into the dressing. 9 The exudate cannot reenter the wound bed and inflammatory cells, especially neutrophils, are sequestered which helps to hasten wound healing. 4 CMC dressings are available in rope and sheet form and the fiber strength of these dressings makes them suitable for loosely packing sinus cavities. 4 CMC dressings do provide a moist wound environment, supporting autolytic debridement as the dressing gels and traps exudate.
Calcium alginate and CMC gelling fiber dressings: Read more ›

Posted in Clinical Insights Newsletter

Choosing The Right Wound Dressing

A wide variety of advanced wound care products are available to treat wounds, from simple dressing materials to sophisticated products. Selecting a wound dressing requires the clinician to be knowledgeable in both the process of tissue repair during wound healing and the intended use of the dressing product selected to treat the wound.1

Dressings are used to:

  • facilitate healing
  • reduce pain
  • contain wound drainage
  • provide adequate moisture for wound healing
  • maintain normothermia in the wound bed
  • minimize bioburden
  • provide a cosmetic covering for the wound

The correct dressing will improve outcomes for wound healing. Dressing selections should be based on a complete clinical assessment addressing wound characteristics, clinical efficacy, and cost of the dressing.1

Wound Characteristics
Dressing selections should be based on the type of tissue present in the wound, wound drainage, bacterial burden, condition of the periwound skin and the wound location.2 Read more ›

Posted in Articles, Clinical Insights Newsletter

DermaRite Industries Appoints Barbara Osborne as Chief Commercial Officer

North Bergen, New Jersey – June 2017 – DermaRite Industries, LLC (“DermaRite”) announced it has named Barbara J. Osborne as Chief Commercial Officer of the company. In her role, Ms. Osborne will be responsible for driving the company’s sales and commercialization efforts.

Ms. Osborne is an experienced healthcare industry executive. Most recently, she served as the U.S. Division President and CEO of LEO Pharma. Previously, Ms. Osborne served as the President of Mölnlycke Health Care’s U.S. Wound Care business.

Ms. Osborne has a broad background encompassing sales, marketing, finance, accounting, business development and R&D. During her tenure in the healthcare industry, she also held senior leadership positions at C.R. Bard, Microtek Medical, and Covidien.

“Ms. Osborne is joining the company at a key stage in our development,” says Naftali Minzer, Chief Executive Officer of DermaRite. “Her extensive experience in the wound care industry and her proven success leading and growing similar size organizations will be a strong addition to our business as we position the company for future growth.”

“I am honored to be joining DermaRite, and I am looking forward to building on the company’s strong foundation,” commented Ms. Osborne. “It is an exciting time to impact the next growth phase of the company.”

Ms. Osborne holds a Master of Science in Accounting from New York University’s Stern School of Business and received her undergraduate degree from Colgate University.

About DermaRite Industries:
DermaRite Industries has been providing high-quality, clinically effective and cost-effective skin and wound care products to nursing homes, home health agencies, hospice and wound clinics for over 20 years. Based in North Bergen, New Jersey, the company’s Healing In D.E.P.T.H. program provides caregivers with the tools and services needed to assure optimal care.

For more information about DermaRite, visit Dermarite.com.

Please direct all inquiries to Yalitza Hernandez, yalitzah@dermarite.com, 973-569-9000 x113.

Posted in Press Release

Senior Digestive Health

Senior Digestive Health

Many systems of the body change with age, including the digestive system. It’s estimated that 40% of seniors experience digestive changes. 1 Many factors impact bowel health and result in constipation including age, medical conditions, poor diet, medications, lack of fiber, inadequate exercise and frequent laxative use. Constipation or diarrhea, a common complaint for seniors, is a symptom the body sends indicating that something is not right.3

What is Constipation?  Simply stated, constipation is infrequent stool elimination. After eating, food is passed through the intestines by a rhythmic, wavelike movement called peristalsis. Intestinal contraction and rest allows food and liquid to be mixed together and propels fecal matter through the digestive tract for elimination. 4 Humans are creatures of habit, and bowel habits will vary. Bowel movements from 3 times per day to once every other day can be considered “normal”. Infrequent stools become hard, difficult to pass, and can cause damage to the nerves and muscles in the rectal area.4 Read more ›

Posted in Articles, Clinical Insights Newsletter

The Results Are In – Healing Never Tasted This Good!

An independent taste test conducted on November 8, 2016 revealed that over 70% of participants preferred the taste of ProHeal™ Liquid Protein when compared to the leading brand.

The blind taste test comparison occurred on 11/8/16 in a dining room of a post-acute care setting using a sample of convenience that included 20 residents and 5 staff members. The residents were from assisted living, long-term care and rehabilitation. All participants were informed of the taste trial for the 2 cherry flavored products (ProHeal™ and ProStat SF®). No food allergies were reported. The facility’s staff conducted the trial and no manufacturer representative was present during the taste test. The samples were unlabeled and the identities of the products were known only to the testers. The subjects reported their preference based on taste after sampling both products.

Results:  

Staff reported preference (n=5):  Prostat=1 (20%); ProHeal=4 (80%).

Residents reported preference (n=20):  Prostat=5 (25%); ProHeal=14 (70%); no preference=1 (5%). Statistical analysis using one sample t-test between the percents shows a statistically significant (p=.031) difference in test preference in favor of ProHeal.

Cumulative staff & residents (n=25):  Prostat=6 (24%); ProHeal=18 (72%); no preference=1 (4%). Statistical analysis using one sample t-test between the percents shows a statistically significant (p=.010) difference in test preference in favor of ProHeal.

This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Click here for more information

Posted in Press Release

Palliative Wound Care

Palliative Wound CarePalliative care is defined by the World Health Organization (WHO) as an “approach that improves quality of life in patients and their families facing the problems associated with life-threatening illnesses”. 1 Palliative care focuses on prevention and relief from suffering, providing pain control, spiritual support and symptom control, done with respect for cultural differences and individual needs. Care decisions should be made through a process that involves open dialogue between patient, family and caregivers. 1 Read more ›

Posted in Articles, Clinical Insights Newsletter